July 2013

Rheonix to Advance Automated Diagnostic Testing Technology through Strategic Partnership

ITHACA, N.Y. – Rheonix, Inc., a developer of fully automated molecular testing solutions, and Life Technologies Corp. (NASDAQ: LIFE), a global leader in the life sciences tools and diagnostic markets, have entered into a joint development agreement to introduce a molecular testing platform for their Applied Markets business. Technology developed by Rheonix for the molecular diagnostics market, including the Rheonix CARD® , a disposable cartridge the size of a credit card… Read More »

Rheonix Workshop to Address Challenges of Implementing Personalized Medicine

ITHACA, N.Y. – Widespread implementation of personalized medicine will depend upon identification of clinically relevant biomarkers, cost-effective methods to detect them and a reimbursement strategy that will meet the needs of all stakeholders. These will be a few of the points raised during a workshop entitled “Implementing Effective and Reimbursable Personalized Medicine” at the upcoming joint annual meeting of the American Association for Clinical Chemistry (AACC) and the American Society for… Read More »